期刊文献+

溃疡性结肠炎合并巨细胞病毒感染的诊治进展 被引量:2

Progress in Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection
暂未订购
导出
摘要 溃疡性结肠炎(ulcerative colitis, UC)是一种病因不明的慢性复发性非特异性炎症性肠病,主要引起结肠黏膜炎症,包括腹泻、便血、腹痛等胃肠道症状。由于通常用皮质类固醇、免疫抑制剂、生物制剂治疗,导致患者的免疫功能受到了一定的抑制作用,进而增加了机会性感染的风险。其中巨细胞病毒(cytomegalovirus, CMV)感染较为常见。因此,CMV感染是UC诱导和维持治疗中的一个棘手问题。故本文就UC合并CMV感染的流行病学、检测手段及治疗策略作一综述。 Ulcerative colitis (UC) is a chronic relapsing nonspecific inflammatory disease of unknown etiology, which mainly causes colonic mucosal inflammation and gastrointestinal symptoms such as diarrhea, blood in the stool, and abdominal pain. Due to the usual treatment with corticosteroids, immuno-suppressants, and biological agents, the patient’s immune function is inhibited to a certain extent, thereby increasing the risk of opportunistic infections. Among them, cytomegalovirus (CMV) infec-tion is more common. Therefore, CMV infection is a thorny problem in the induction and mainte-nance therapy of UC. Therefore, this article reviews the epidemiology, detection methods and treatment strategies of UC complicated with CMV infection.
出处 《临床医学进展》 2022年第8期7627-7633,共7页 Advances in Clinical Medicine
  • 相关文献

参考文献5

二级参考文献232

  • 1Hideyuki Suzuki,Jun Kato,Motoaki Kuriyama,Sakiko Hiraoka,Kenji Kuwaki,Kazuhide Yamamoto.Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection[J].World Journal of Gastroenterology,2010,16(10):1245-1251. 被引量:21
  • 2Pilar López-Serrano,Jose Lázaro Pérez-Calle,Maria Dolores Sánchez-Tembleque.Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis[J].World Journal of Gastroenterology,2013,19(9):1342-1348. 被引量:12
  • 3Axel Dignass,Rami Eliakim,Fernando Magro,Christian Maaser,Yehuda Chowers,Karel Geboes,Gerassimos Mantzaris,Walter Reinisch,Jean-Frederic Colombel,Severine Vermeire,Simon Travis,James O. Lindsay,Gert Van Assche.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis[J].Journal of Crohn’s and Colitis.2012(10)
  • 4Sylvie Pillet,Bruno Pozzetto,Camille Jarlot,Stéphane Paul,Xavier Roblin.Management of cytomegalovirus infection in inflammatory bowel diseases[J].Digestive and Liver Disease.2012(7)
  • 5GarrettLawlor,Alan C.Moss.Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?[J].Inflamm Bowel Dis.2010(9)
  • 6M. Green,M. G. Michaels.Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder[J]. American Journal of Transplantation . 2013 (s3)
  • 7Rachmilewitz D.Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. British Medical Journal . 1989
  • 8Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut . 2006
  • 9J. A. Fishman.Overview: Cytomegalovirus and the Herpesviruses in Transplantation[J]. American Journal of Transplantation . 2013 (s3)
  • 10Milena Furione,Vanina Rognoni,Ermanna Cabano,Fausto Baldanti.Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTi m e CMV assay and an in-house assay[J]. Journal of Clinical Virology . 2012 (4)

共引文献76

同被引文献28

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部